appScorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
Nectar Lifesciences Ltd
NECLIFE
Price Chart
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
Key MetricsEdit
Forecast & RatingsDetailed Forecast
Price
Price Upside
—
Earnings
Earnings Growth
—
Revenue
Rev. Growth
—
Company Profile
Nectar Lifesciences Limited is a pharmaceutical company. The Company's operations include manufacturing and marketing of oral and sterile cephalosporin's, phytochemicals and allied products.
PeersCompare with peers
Sun Pharmaceutical Industries Ltd
Cipla Ltd
Torrent Pharmaceuticals Ltd
Dr Reddy's Laboratories Ltd
Zydus Lifesciences Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Financial TrendFinancial statements
Holdings TrendDetailed holdings
High Pledged Promoter HoldingLower pledged promoter holdings is considered better
A significant proportion of promoter holdings is pledged
Mutual Fund HoldingIncreasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock
In last 3 months, mutual fund holding of the company has almost stayed constant
Recent NewsAll news
Hmm, looks like data is unavailable here. Please come back after some timeRecent EventsAll events
Notice Of Shareholders Meetings-XBRL
NECTAR LIFESCIENCES LIMITED has informed the Exchange about Notice of Shareholders Meeting for Annual General Meeting to be held on 21-Sep-2024 | Download
NECTAR LIFESCIENCES LIMITED has informed the Exchange about Notice of Shareholders Meeting for Annual General Meeting to be held on 21-Sep-2024 | Download
Outcome of Board Meeting
Nectar Lifesciences Limited has informed the Exchange regarding Board meeting held on August 14, 2024:1. To convene the 29th Annual General Meeting ("AGM") of the Members of the company on Saturday, September 21, 2024; 2. To close the Register of Members and Share Transfer Books from September 15, 2024 to September 21, 2024 (Both days inclusive) for the purpose of AGM. Accordingly, the cut-off date, to ascertain the eligibility of members for remote e-voting and polling/ e-voting at AGM, is September 14, 2024 i.e., the date prior to the commencement of book closure; 3. The Re-appointment of Mr. Puneet Sud (DIN 09735713) as Director (Operations) of the Company; 4. The Re-appointment of Mr. Sanjiv Goyal (DIN: 00002841) as a Chairman & Managing Director. | Download
Nectar Lifesciences Limited has informed the Exchange regarding Board meeting held on August 14, 2024:1. To convene the 29th Annual General Meeting ("AGM") of the Members of the company on Saturday, September 21, 2024; 2. To close the Register of Members and Share Transfer Books from September 15, 2024 to September 21, 2024 (Both days inclusive) for the purpose of AGM. Accordingly, the cut-off date, to ascertain the eligibility of members for remote e-voting and polling/ e-voting at AGM, is September 14, 2024 i.e., the date prior to the commencement of book closure; 3. The Re-appointment of Mr. Puneet Sud (DIN 09735713) as Director (Operations) of the Company; 4. The Re-appointment of Mr. Sanjiv Goyal (DIN: 00002841) as a Chairman & Managing Director. | Download
Cash Dividend
Final • Div/Share: ₹ 0.05
Total Promoter HoldingIncreasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant